Target intelligence / Profile preview

Bacterial 50S ribosomal subunit (Cutibacterium acnes) (50S ribosome)

Target
50S ribosome
Molecular classification
Ribonucleoprotein complex, Ribosome, Enzyme
01

Overview

The bacterial 50S ribosomal subunit is the larger component of the 70S ribosome in prokaryotes, including the skin-associated bacterium Cutibacterium acnes (StatPearls, 2023). It plays a fundamental role in protein synthesis by catalyzing peptide bond formation via its peptidyl transferase center and facilitating the translocation of the nascent peptide chain (NCBI, 2022). In the context of dermatology, the 50S subunit is a primary target for several classes of antibiotics, such as macrolides and lincosamides, which are used to treat acne vulgaris (Mayo Clinic, 2023). These drugs bind to the 23S ribosomal RNA within the subunit, obstructing the exit tunnel or the active site, thereby inhibiting bacterial growth and reducing the inflammatory response triggered by C. acnes (PubMed, 2021). The clinical utility of targeting this subunit is increasingly threatened by the emergence of resistant strains, often mediated by ribosomal methylation or point mutations in the rRNA (Journal of Antimicrobial Chemotherapy, 2020).

Other names
Large ribosomal subunit50S subunitPropionibacterium acnes 50S ribosome23S rRNA-protein complexProkaryotic 50S ribosomal subunit
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to the 50S ribosomal subunit, specifically the 23S rRNA, which prevents peptide bond formation or translocation of the tRNA-peptide complex (StatPearls, 2023).

03

Biological functions

Protein synthesisTranslationPeptidyl transferase activityPeptide bond formation
04

Disease associations

Acne vulgarisInfectionInflammation
05

Safety considerations

Development of antibiotic resistanceSkin microbiome dysbiosisGastrointestinal distress (with oral administration)Pseudomembranous colitis (rare complication of lincosamide use)Cross-resistance between macrolides, lincosamides, and streptogramins (MLS resistance)
06

Interacting drugs

Clindamycin

8 more in the full profile.

07

Biomarkers

Bacterial load of Cutibacterium acneserm(X) gene expression23S rRNA mutations (e.g., A2058G, A2059G)16S rRNA sequencing for strain identification

Beyond the preview

Go deeper on Bacterial 50S ribosomal subunit (Cutibacterium acnes) (50S ribosome).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 50S ribosomal subunit (Cutibacterium acnes) (50S ribosome).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call